Projects in multiple myeloma

Abbvie – Profile of patients in Intent-to-Treat with CAR T-cells, and Efficacy and Safety in Large B-Cell Lymphomas

BMS – Profile of patients in Intent-to-Treat with CAR T-cells, and Efficacy and Safety in relapsed or refractory Large B-Cell Lymphomas

Comparative control arm of Phase II clinical trial BICAR with the DESCAR-T registry

Patients above 80 eligible for CAR-T therapy

Efficacy and safety of CAR-T in the treatment of primary mediastinal lymphoma

Efficacy of CAR-T administered close to a treatment by anti-CD19 antibody

Analysis of fungal infections after CAR-T

Treating transformed Waldenstrom Macroglobulinemia (WM) with CAR T-cells

CAR-TRANS – Transfusion needs of patients treated with CAR-T cells

Use of Siltuximab in the treatment of Cytokine Release Syndromes

Miltenyi – CAR-T efficacy and safety in diffuse large B-cell lymphoma

Analysis of deaths after CAR-T not related to disease progression

CARLATE – Outcome of patients relapsing more than 3 months after CAR T-Cell therapy

CAR-T cells after progression/relapse following treatment by bispecific antibody

CAR-T cells after progression/relapse following treatment by bispecific antibody for Spanish and French Patients

Treating Richter Syndrome with CAR-T

Analysis of neurotoxicities following treatment by CAR-T cells

Efficacy and safety of CAR-T in Mantle Cell Lymphoma